Administration of human protein C improves survival in an experimental model of sepsis

Critical Care Medicine

Volumn 38, Issue 1, 2010, Pages 209-216

  Messaris, Evangelos ^a   Betrosian, Alex P ^c   Memos, Nikolaos ^a   Chatzigianni, Emmy ^a   Boutsikou, Maria ^a   Economou, Venetia ^a   Dontas, Ismene ^a   Theodossiades, George ^c   Konstadoulakis, Manousos M ^a   Douzinas, Emmanuel E ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Apoptosis; Protein C zymogen; Sepsis; Survival

Indexed keywords

ALPHA 1 ANTITRYPSIN; INTERLEUKIN 6; PLACEBO; PROTEIN C; TUMOR NECROSIS FACTOR; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN TISSUE; CECUM; COLON; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEART; KIDNEY PARENCHYMA; LIGATION; LUNG PARENCHYMA; MALE; NONHUMAN; ORGAN INJURY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUNCTURE; RAT; SEPSIS; STOMACH; SURVIVAL; ANIMAL; BLOOD; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MORTALITY; NICK END LABELING; NONPARAMETRIC TEST; PATHOLOGY; PROBABILITY; RANDOMIZATION; SURVIVAL RATE; WISTAR RAT;

ANIMALS; CECUM; CHI-SQUARE DISTRIBUTION; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KAPLAN-MEIERS ESTIMATE; LIGATION; MALE; PROBABILITY; PROTEIN C; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEPSIS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE;

EID: 74049089208     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181b4a972     Document Type: Article

References (34)

1. Esmon CT, Gu JM, Xu J, et al: Regulation and functions of the protein C anticoagulant pathway. Haematologica 1999; 84:363-368
2. Esmon CT: The endothelial protein C receptor. Curr Opin Hematol 2006; 13:382-385
3. Taylor FB Jr, Chang A, Esmon CT: Protein C prevents the coagulopathic and lethal effects of E. coli infusion in the baboon. J Clin Invest 1987; 79:918-925
4. Haley M, Cui X, Minnecci PC, et al: Activated protein C in sepsis: Emerging insights regarding its mechanism of action and clinical effectiveness. Current Opin Infect Dis 2004; 17:205-211
5. Dhainaut JF, Yan SB, Claessens YE: Protein C/activated protein C pathway: Overview of clinical trial results in severe sepsis. Crit Care Med 2004; 32:S194-S201
6. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
7. Stephenson DA, Toltl LJ, Beaudin S, et al: Modulation of monocyte function by activated protein C, a natural anticoagulant. J Immunol 2006; 177:2115-2122
8. Cheng T, Liu D, Griffin JH, et al: Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 2003; 9:338-342
9. Rintala E, Kauppila M, Seppala OP, et al: Protein C substitution in sepsis-associated purpura fulminans. Crit Care Med 2000; 28: 2373-2378
10. Betrosian AP, Balla M, Kofinas G, et al: Protein C in the treatment of coagulopathy in meningococcal sepsis. Crit Care Med 1999; 27:2849-2850
11. Alberio L, Lammle B, Esmon CT: Protein C replacement in severe meningococcemia: Rationale and clinical experience. Clin Infect Dis 2001; 32:1338-1346
12. de Kleijn ED, de Groot R, Hack CE, et al: Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulmi-nans: A randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med 2003; 31:1839-1847
13. White B, Livingstone W, Murphy C, et al: An open-label study of the role of adjuvant he-mostatic support with protein C replacement therapy in purpura fulminans-associated me-ningococcemia. Blood 200; 96:3719-3724
14. Mosnier LO, Griffin JH. Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities. Front Bio-sci 2006; 11:2381-2399
15. Faust SN, Levin M, Harrison OB, et al: Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001; 345:408-416 (Pubitemid 32747604)
16. Liaw PCY. Endogenous protein C activation in patients with severe sepsis. Crit Care Med 2004; 32:S214-S218
17. Feistritzer C, Schuepbach RA, Mosnier LO, et al: Protective signaling by activated protein C is mechanistically linked to protein C activation on endothelial cells. J Biol Chem 2006; 281:20077-20084
18. Brunkhorst F, Sakr Y, Hagel S, et al: Protein C concentrations correlate with organ dysfunction and predict outcome independent of the presence of sepsis. Anesthesiology 2007; 107: 15-23
19. Hoogendoom H, Neisheim ME, Giles AR: A qualitative and quantitive analysis of the activation and inactivation of protein C in vivo in a primate model. Blood 1990; 75:2164-2171
20. Scully MF, Toh CH, Hoogendoom H, et al: Activation of protein C and its distribution between its inhibitors, protein C inhibitor, a1-Antithypsin and a2 macroglobulin, in patients with disseminated intravascular coagulation. Throm Haemostasis 1993; 69: 448-453
21. Speekenbrink RG, Bertina RM, España F, et al: Activation of the protein C system during cardiopulmonary bypass with and without aprotinin. Ann Thorac Surg 1998; 66: 1998-2002
22. Bhiladvala P, Strandberg K, Stenflo J, et al: Early identification of acute myocardial infarction by activated protein C-protein C inhibitor complex. Thromb Res 2006; 118: 213-219
23. Hubbard WJ, Choudhry M, Schwacha MG, et al: Cecal ligation and puncture. Shock 2005; 24:S52-S57
24. Xiao H, Siddiqui J, Remick DG. Mechanisms of mortality in early and late sepsis. Infect Immun 2006; 74:5227-5235
25. Remick DG, Bolgos GR, Siddiqui J, et al: Six at six: Interleukin-6 measured 6h after the initiation of sepsis predicts mortality over 3 days. Shock 2002; 17:463-467
26. Jackson CJ, Xue M: Activated protein C\-An anticoagulant that does more than stop clots. Int J Biochem Cell Biol 2008; 40:2692-2697
27. Sharma GR, Gerlitz B, Berg DT, et al: Activated protein C modulates chemokine response and tissue injury in experimental sepsis. Adv Exp Med Biol 2008; 614:83-91
28. Sturn DH, Kaneider NC, Feistritzer C, et al: Expression and function of the endothelial protein C receptor in human neutrophils. Blood 2003; 102:1499-1505
29. Abraham E: Effects of recombinant human activated protein C in human models of en-dotoxin administration. Proc Am Thorac Soc 2005; 2:243-247
30. Hotchkiss RS, Tinsley KW, Karl IE: Role of apoptotic cell death in sepsis. Scand J Infect Dis 2003; 35:585-592
31. Wesche-Soldato DE, Lomas-Neira JL, Perl M, et al: The role and regulation of apoptosis in sepsis J Endotoxin Res 2005; 11:375-382
32. Wan L, Bagshaw SM, Langenberg C, et al: Pathophysiology of septic acute kidney injury: What do we really know? Crit Care Med 2008; 36:S198-S203
33. Joyce DE, Gelbert L, Ciaccia A, et al: Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 2001; 276:11199-11203
34. Bae JS, Yang L, Rezaie AR. Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proc Natl Acad Sci U S A 2007; 104:2867-2872